Last edition
News about "Anbogen Therapeutics"
Anbogen Therapeutics Secures Additional USD 7.3 Million in A+ Round Financing
Anbogen Therapeutics, Inc. has received USD 7.3 million oversubscribed A+ round financing, which is a direct continuation of the USD 12.5 Million Series A on February 1, 2024, bringing the total raised to USD 19.8 million.
Anbogen Therapeutics | 02/07/2024 | By Aishwarya | 296
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members